IL1B and COVID-19: These observations are consistent with our results here, showing a significant increase in IL-1β in people with both Cov and nLongC months to years after infection with SARS-CoV-2 compared to pre-COVID-19 healthy controls (Figure 3) and that the recovered Cov cohort had a decrease in IL-1β over time while the nLongC cohort did not (Figure 7).